News

The United States saw a dramatic increase in fireworks-related deaths and injuries last year. Here's how to stay safe.
AstraZeneca PLC (NASDAQ:AZN) is one of the 11 Best Strong Buy Stocks to Invest in Now. On June 13, AstraZeneca PLC ...
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.
The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.
CSPC has a very strong financial position. As of 2022, its total debt outstanding is only 1.8% of its total cash in hand. Its annual capital expenditure for 2022 was CNY 1.8 billion.
On June 13, 2025, AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel oral candidates ...
CSPC Pharma pocketed $150 million upfront and retains the right to up to $135 million in staged development payments and up to $1.55 billion in fees related to sales milestones.
CSPC Pharmaceutical Group, with a market cap of HK$50.61 billion, has been actively expanding its R&D efforts despite recent revenue challenges due to declining caffeine prices and health food sales.
Access CSPC Pharma stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.
These are the faucets, all made by firms in China and sold on Amazon, covered by the CSPC warning: Ceinol brand bathroom faucets: The faucets, priced at about $55, ...
AstraZeneca said it entered into a strategic research collaboration with China’s CSPC Pharmaceuticals, focused on artificial intelligence-driven research, valued at up to $5.33 billion.